ANI Pharmaceuticals (ANIP) Stock Insights

ANIP price $71.71 +0.54 +0.76%

Ticker
ANIP
Price
$71.71
Change
+0.54 +0.76%
Market cap ?
$1.65B
P/E ?
15.00
Forward P/E ?
7.74
Dividend yield ?
0.00%
Beta ?
0.49
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stocklytics score
75
Value
76
Quality
73
Growth
76

Stocklytics score rationale: value 76, quality 73, growth 76.

Financials

2016201720182019202020212022202320242025
128622000176842000201576000206547000208475000216136000316385000486816000614376000883366000

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The…

Fair value

ANIP fair value $309.55. Price $71.71. Price is 77% below fair value.

Below fair value, and cheaper than usual. A larger discount than on more than 99% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 99.47M. Growth 14.25%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 22.96M. Net debt 39.61M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare ANIP

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—2.18—280.26M
2026-08-072.212.04266.04M260.13M
2026-05-082.051.28237.46M207.63M
2026-02-272.331.99247.06M231.09M
2025-11-072.041.74227.81M232.25M
2025-08-081.801.38211.37M208.81M
2025-05-091.701.37197.12M188.73M
2025-02-281.631.41190.57M169.96M
2024-11-081.341.09148.33M175.12M
2024-08-061.020.93138.04M129.05M
2024-05-101.210.98137.43M125.52M
2024-02-291.000.80131.65M122.21M
2023-11-081.270.76131.83M122.25M
2023-08-091.280.64116.55M98.70M
2023-05-081.170.34106.79M83.49M
2023-03-090.760.6894.23M86.14M
2022-11-090.640.5883.82M78.36M
2022-08-080.130.1273.86M71.97M
2022-05-10-0.120.0864.48M65.03M
2022-03-150.540.8260.93M56.30M
2021-11-011.010.7152.06M49.70M
2021-08-060.670.6548.62M48.05M
2021-05-071.040.7354.52M48.15M
2021-03-090.801.0057.25M—
2020-11-050.970.9252.98M48.06M
2020-08-060.690.7148.47M59.71M
2020-05-071.040.8949.77M42.60M
2020-02-271.081.1847.97M52.41M
2019-11-061.231.4851.34M59.68M
2019-08-071.441.2954.36M48.69M
2019-05-091.301.0352.89M42.72M
2019-02-271.321.2557.12M53.66M
2018-11-061.291.2250.70M45.99M
2018-08-071.131.3047.27M56.05M
2018-05-081.321.1946.48M44.72M
2018-02-271.081.0947.29M46.85M
2017-11-021.110.9948.16M42.96M
2017-08-030.980.8744.76M39.28M
2017-05-040.740.7736.63M38.11M
2017-03-020.901.1338.20M49.58M

Dividends

Yield 0.00%. Payout ratio 0.33%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-15Lalwani NikhilSell5.40K$71.89388.21K
2026-10-13Cook MeredithSell500$73.5936.80K
2026-09-29CAREY STEPHEN P.Sell2.85K$73.00208.05K
2026-09-15Lalwani NikhilSell5.40K$71.00383.40K
2026-09-14Cook MeredithSell500$70.7935.40K
2026-09-11Thoma JeanneSell1.00K$71.5371.53K
2026-08-31CAREY STEPHEN P.Sell2.85K$72.80207.48K
2026-08-25Lalwani NikhilSell5.40K$74.30401.22K
2026-08-19Gosebruch Henry OBuy6.66K——
2026-08-19Gosebruch Henry OOther0——
2026-08-13Cook MeredithSell500$75.4837.74K
2026-08-10Gutwerg OriSell3.16K$77.00243.47K
2026-07-29CAREY STEPHEN P.Sell2.85K$81.36231.88K
2026-07-18Cook MeredithSell2.47K$79.20195.31K
2026-07-13Cook MeredithSell500$81.8440.92K
2026-07-02CAREY STEPHEN P.Buy3.31K$49.51164.03K
2026-07-02CAREY STEPHEN P.Sell3.31K$86.00284.92K
2026-07-02CAREY STEPHEN P.Sell3.31K$49.51164.03K
2026-06-29CAREY STEPHEN P.Sell2.85K$84.12239.74K
2026-06-12Cook MeredithSell500$82.0341.02K
2026-06-08HAUGHEY THOMASSell2.00K$80.88161.76K
2026-06-05CAREY STEPHEN P.Buy3.31K$49.51163.98K
2026-06-05CAREY STEPHEN P.Sell3.31K$80.00264.96K
2026-06-05CAREY STEPHEN P.Sell3.31K$49.51163.98K
2026-05-21Thoma JeanneBuy4.36K——
2026-05-21TANNENBAUM RENEE PBuy4.36K——
2026-05-21Pera Antonio RBuy4.36K——
2026-05-21Leonard Matthew JBuy4.36K——
2026-05-21HAUGHEY THOMASBuy4.36K——
2026-05-13Walsh Patrick DSell10.00K$80.63806.30K
2026-05-13Cook MeredithSell500$78.1639.08K
2026-05-12Rowland Thomas AndrewSell459$79.2136.36K
2026-05-12Gutwerg OriSell2.77K$79.50220.37K
2026-05-11Walsh Patrick DSell3.97K$80.75320.82K
2026-05-11Lalwani NikhilSell55.00K$77.574.27M
2026-04-13Cook MeredithSell500$77.9538.98K
2026-03-13Mutz ChristopherSell3.16K$71.64226.53K
2026-03-13Cook MeredithSell500$72.6236.31K
2026-03-11Rowland Thomas AndrewSell4.77K$74.91357.47K
2026-03-09Mutz ChristopherSell3.60K$74.18267.20K
2026-03-09Davis KristaSell5.09K$74.13377.10K
2026-03-07Mutz ChristopherSell3.31K$74.04245.37K
2026-03-07Lalwani NikhilSell17.06K$74.041.26M
2026-03-07Gutwerg OriSell3.31K$74.04245.37K
2026-03-07CAREY STEPHEN P.Sell5.15K$74.04381.31K
2026-03-06Mutz ChristopherSell2.12K$74.22157.42K
2026-03-06Davis KristaSell1.49K$75.00111.38K
2026-03-05CAREY STEPHEN P.Buy3.31K$49.51163.98K
2026-03-05CAREY STEPHEN P.Sell3.31K$75.42249.79K
2026-03-05CAREY STEPHEN P.Sell4.00K$75.56302.24K
2026-03-05CAREY STEPHEN P.Sell3.31K$49.51163.98K
2026-03-03Gutwerg OriSell2.06K$76.50157.59K
2026-03-03Walsh Patrick DSell6.00K$74.23445.38K
2026-03-02Mutz ChristopherSell417$74.0030.86K
2026-02-28Rowland Thomas AndrewSell628$73.9046.41K
2026-02-28Mutz ChristopherSell2.22K$73.90164.13K
2026-02-28Lalwani NikhilSell12.22K$73.90902.84K
2026-02-28Gutwerg OriSell2.22K$73.90164.13K
2026-02-28Gassert ChadSell2.22K$73.90164.13K
2026-02-28Davis KristaSell1.55K$73.90114.91K
2026-02-28Cook MeredithSell1.55K$73.90114.91K
2026-02-28CAREY STEPHEN P.Sell2.77K$73.90204.92K
2026-02-26Shanmugam MuthusamyBuy11.12K$77.15857.60K
2026-02-26Rowland Thomas AndrewBuy6.02K$77.15464.52K
2026-02-26Mutz ChristopherBuy21.31K$77.151.64M
2026-02-26Lalwani NikhilBuy75.59K$77.155.83M
2026-02-26Gutwerg OriBuy12.97K$77.151.00M
2026-02-26Gassert ChadBuy11.12K$77.15857.60K
2026-02-26Davis KristaBuy10.81K$77.15833.99K
2026-02-26Cook MeredithBuy13.89K$77.151.07M
2026-02-26CAREY STEPHEN P.Buy22.23K$77.151.72M
2026-02-20Mutz ChristopherSell5.32K$78.02415.30K
2026-02-20Davis KristaSell1.73K$77.99134.92K
2026-02-19Davis KristaSell2.08K$77.53161.57K
2026-02-14Rowland Thomas AndrewSell485$77.3637.52K
2026-02-14Mutz ChristopherSell2.40K$77.36185.90K
2026-02-14Lalwani NikhilSell10.30K$77.36796.65K
2026-02-14Gutwerg OriSell1.89K$77.36146.06K
2026-02-14Gassert ChadSell1.72K$77.36132.83K
2026-02-14Davis KristaSell1.29K$77.3699.79K
2026-02-14Cook MeredithSell1.78K$77.36137.62K
2026-02-14CAREY STEPHEN P.Sell2.45K$77.36189.38K
2026-02-13Cook MeredithSell500$76.8038.40K
2026-02-12Rowland Thomas AndrewSell566$76.7043.41K
2026-02-12Mutz ChristopherSell3.17K$76.70243.37K
2026-02-12Mutz ChristopherSell7.03K$76.55538.30K
2026-02-12Lalwani NikhilSell11.69K$76.70896.47K
2026-02-12Gutwerg OriSell1.77K$76.70136.14K
2026-02-12Gassert ChadSell1.61K$76.70123.33K
2026-02-12Davis KristaSell1.18K$76.7090.51K
2026-02-12Cook MeredithSell1.53K$76.70117.66K
2026-02-12CAREY STEPHEN P.Sell2.83K$76.70216.98K
2026-02-11CAREY STEPHEN P.Sell5.50K$76.25419.60K
2026-02-11Cook MeredithSell3.01K$76.25229.59K
2026-02-11Davis KristaSell3.02K$76.25230.05K
2026-02-11Gassert ChadSell4.27K$76.25325.51K
2026-02-11Gutwerg OriSell4.27K$76.25325.36K
2026-02-11Lalwani NikhilSell30.66K$76.252.34M
2026-02-11Mutz ChristopherSell4.55K$76.25346.63K
2026-02-11Rowland Thomas AndrewSell1.76K$76.25134.35K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 315, holders +27 vs prior quarter. Ownership 109.74%.

HolderSharesChangeChange %Value
BLACKROCK, INC.2.96M211.15K+7.69%244.92M
SOLEUS CAPITAL MANAGEMENT, L.P.867.76K47.52K+5.79%71.83M
VANGUARD CAPITAL MANAGEMENT LLC838.22K15.16K+1.84%69.39M
STATE STREET CORP831.65K60.06K+7.78%68.86M
TANG CAPITAL MANAGEMENT LLC707.50K00.00%58.57M
DIMENSIONAL FUND ADVISORS LP623.46K92.27K+17.37%51.61M
AMERICAN CENTURY COMPANIES INC574.47K382.90K+199.87%47.55M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP562.02K-2.34K-0.42%46.52M
GLOBAL ALPHA CAPITAL MANAGEMENT LTD.558.00K196.76K+54.47%46.19M
GEODE CAPITAL MANAGEMENT, LLC536.41K47.21K+9.65%44.41M
MILLENNIUM MANAGEMENT LLC507.21K-84.81K-14.33%41.99M
NUVEEN, LLC415.02K12.67K+3.15%34.36M
VANGUARD PORTFOLIO MANAGEMENT LLC407.28K31.32K+8.33%33.71M
RANGER INVESTMENT MANAGEMENT, L.P.343.15K-16.93K-4.70%28.41M
DEUTSCHE BANK AG\323.44K3.77K+1.18%26.77M
INVESCO LTD.309.23K-15.12K-4.66%25.60M
UBS GROUP AG297.54K-200.16K-40.22%24.63M
KENNEDY CAPITAL MANAGEMENT LLC295.94K1.94K+0.66%24.50M
AMERIPRISE FINANCIAL INC287.38K17.12K+6.33%23.79M
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.287.21K-357-0.12%23.77M
IKARIAN CAPITAL, LLC272.08K125.00K+84.98%22.52M
ABERDEEN GROUP PLC271.76K65.64K+31.84%22.50M
OBERWEIS ASSET MANAGEMENT INC/265.31K43.92K+19.84%21.96M
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC258.17K-69.10K-21.11%21.37M
RUBRIC CAPITAL MANAGEMENT LP258.13K258.13KNew21.37M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

ANI Pharmaceuticals (ANIP) Stock Insights

ANIP$71.71+0.54 +0.76%

$1.65B

Market Cap

15.00

P/E

7.74

Forward P/E

75

Score

Price History